Can Biomarkers Guide the Use of Neoadjuvant Chemotherapy in T2 Bladder Cancer?

MLA

Grossman, H.Barton, et al. “Can Biomarkers Guide the Use of Neoadjuvant Chemotherapy in T2 Bladder Cancer?” European Urology Oncology, vol. 2, no. 5, Sept. 2019, pp. 597–602. EBSCOhost, https://doi.org/10.1016/j.euo.2019.06.002.

APA

Grossman, H. B., Bellmunt, J., & Black, P. C. (2019). Can Biomarkers Guide the Use of Neoadjuvant Chemotherapy in T2 Bladder Cancer? European Urology Oncology, 2(5), 597–602. https://doi.org/10.1016/j.euo.2019.06.002

Chicago

Grossman, H Barton, Joaquim Bellmunt, and Peter C Black. 2019. “Can Biomarkers Guide the Use of Neoadjuvant Chemotherapy in T2 Bladder Cancer?” European Urology Oncology 2 (5): 597–602. doi:10.1016/j.euo.2019.06.002.